Testing a Mammography Decision Intervention in a Rural Setting
Part of paid clinical trials in Keene, New Hampshire.
- Sponsor
- Dartmouth-Hitchcock Medical Center
- Study ID
- NCT06522568
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- 39 Years - 49 Years
- Healthy Volunteers
- Not accepted
Interventions
- MyMammogram — BEHAVIORALAn online breast cancer screening decision aid
- Provider communication — OTHERProvider will be provided with information from MyMammogram that includes patient's breast cancer risk and preferences for mammograms prior to the appointment
Study Details
The overall objective of this COBRE pilot project is to enhance the design of a 3-arm cluster randomized trial that will test the efficacy and mechanism of effect of the MyMammogram DA with or without a provider communication intervention. This will be accomplished through two aims: (1) Refine, with community partner input, a clinical trial protocol to optimize engagement among patients and primary care providers (PCPs) practicing in rural settings. In consultation with patients, PCPs, and informatics experts, the study team will refine site selection, randomization, patient and PCP recruitment, and data collection protocols to meet the needs of the rural health care delivery system and participants. The result of this aim will be a modified protocol and intervention strategy that is acceptable to partners. (2) Adapt and test trial and intervention implementation features to achieve protocol acceptance and adherence. The investigators will pilot the adapted three-arm randomized trial protocol in rural primary care settings that compares the MyMammogram DA with or without a risk summary provided to the PCP pre-visit, relative to usual care. Implementing the trial in two phases (n=15 each) will systematically identify barriers and facilitators to trial participation to refine protocols. Participants will receive acceptability surveys and investigators will conduct qualitative interviews with patients and PCPs to understand experiences with trial implementation from multiple perspectives.
Key Dates
- Start date
- Sep 1, 2025
- Status verified
- May 2026
- Primary completion
- Sep 15, 2026
- Completion
- Sep 15, 2026
Study Design
- Enrollment
- 39 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- No Intervention: Usual CareUsual care.
- Experimental: MyMammogramPatient uses MyMammogram prior to appointment.
- Experimental: MyMammogram plus provider communicationPatient uses MyMammogram prior to appointment. Provider receives a summary from MyMammogram prior to appointment.
Primary Outcome Measure
Intervention acceptability [ Time Frame: within one day of completing the intervention ]
Central Contacts
- Christine M Gunn, PhD603-646-5430
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cheshire Medical Center | Keene | New Hampshire | 03431 |
Find similar trials in Keene, NH
Related Studies
- Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast CancerPHASE3 · Recruiting · Canadian Cancer Trials Group · Fairbanks, Alaska
- ATEMPT 2.0: Adjuvant T-DM1 vs THPHASE2 · Recruiting · Dana-Farber Cancer Institute · San Francisco, California
- Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25PHASE3 · Recruiting · NRG Oncology · Birmingham, Alabama
- Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer SurvivorsRecruiting · NRG Oncology · Anchorage, Alaska